Skip to main navigation Skip to search Skip to main content

Study to Compare the Effect of 24 Weeks Treatment with LAF237 to Placebo as Add-On Therapy in Patients with Type 2 Diabetes Treated with Insulin

Project: Research

Project Details

StatusFinished
Effective start/end date07/1/04 → 09/1/06

Funding

  • Novartis Pharmaceuticals Corporation: $619.32